Global RNA-Targeted Small Molecules Market to Witness 6.1% Growth during 2022
/PRNewswire/ -- According to the report published by Absolute Markets Insights, the global RNA-targeted small molecules market is projected to grow at a CAGR...
Stay updated with breaking news from Skyhawk Small. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- According to the report published by Absolute Markets Insights, the global RNA-targeted small molecules market is projected to grow at a CAGR...
/PRNewswire/ -- According to the report published by Absolute Markets Insights, the global RNA-targeted small molecules market is projected to grow at a CAGR...
PUNE, India, March 8, 2022 /PRNewswire/ -- According to the report published by Absolute Markets Insights, the global RNA-targeted small molecules market is projected to grow at a CAGR of 6.1%
Skyhawk Therapeutics Expands Leadership Team, Appointing Elliot Ehrich MD as President and Graeme Smith PhD as SVP NonClinical Development News provided by Share this article Share this article Elliot Ehrich MD brings 25+ years R&D and clinical development leadership experience to the company; Graeme Smith PhD DABT brings 15+ years of nonclinical drug development leadership experience to the company. WALTHAM, Mass., April 13, 2021 /PRNewswire/ -- Skyhawk Therapeutics today announced the appointments of Dr. Elliot Ehrich as its President, and Dr. Graeme Smith as its Senior Vice President of N...